Cargando…
EPAC1 Pharmacological Inhibition with AM-001 Prevents SARS-CoV-2 and Influenza A Virus Replication in Cells
The exceptional impact of the COVID-19 pandemic has stimulated an intense search for antiviral molecules. Host-targeted antiviral molecules have the potential of presenting broad-spectrum antiviral activity and are also considered as less likely to select for resistant viruses. In this study, we inv...
Autores principales: | Foret-Lucas, Charlotte, Figueroa, Thomas, Bertin, Alexandre, Bessière, Pierre, Lucas, Alexandre, Bergonnier, Dorian, Wasniewski, Marine, Servat, Alexandre, Tessier, Arnaud, Lezoualc’h, Frank, Volmer, Romain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965159/ https://www.ncbi.nlm.nih.gov/pubmed/36851533 http://dx.doi.org/10.3390/v15020319 |
Ejemplares similares
-
Modeling Epac1 interactions with the allosteric inhibitor AM-001 by co-solvent molecular dynamics
por: Bufano, Marianna, et al.
Publicado: (2020) -
Cyclic AMP-binding protein Epac1 acts as a metabolic sensor to promote cardiomyocyte lipotoxicity
por: Laudette, Marion, et al.
Publicado: (2021) -
GRKs and Epac1 Interaction in Cardiac Remodeling and Heart Failure
por: Laudette, Marion, et al.
Publicado: (2021) -
Role of EPAC1 Signalosomes in Cell Fate: Friends or Foes?
por: Formoso, Karina, et al.
Publicado: (2020) -
The Epac1 Protein: Pharmacological Modulators, Cardiac Signalosome and Pathophysiology
por: Bouvet, Marion, et al.
Publicado: (2019)